FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386222848> ?p ?o ?g. }

• W4386222848 endingPage "2402" @default.
• W4386222848 startingPage "2402" @default.
• W4386222848 abstract "Background: Renal failure in COVID-19 patients is reportedly related to multiple factors such as a direct SARS-CoV-2 cytopathic effect, cytokine storm, the association of pulmonary and/or cardiovascular lesions, the presence of thrombotic microangiopathy, endothelial damage, or the use of potentially nephrotoxic medications. Methods: We retrospectively analyzed 466 cases of SARS-CoV-2 infection, comparing 233 patients with acute kidney injury (AKI) with 233 patients without AKI in terms of their demographic characteristics, comorbidities, clinical background, laboratory investigations, time of AKI onset, therapy, and outcomes after using univariate analysis and a CART decision-tree approach. The latter was constructed in a reverse manner, starting from the top with the root and branching out until the splitting ceased, interconnecting all the predictors to predict the overall outcome (AKI vs. non-AKI). Results: There was a statistically significant difference between the clinical form distribution in the two groups, with fewer mild (2 vs. 5) and moderate (54 vs. 133) cases in the AKI group than in the non-AKI group and more severe and critical patients in the AKI cohort (116 vs. 92 and 60 vs. 3). There were four deaths (1.71%) in the non-AKI group and 120 deaths in the AKI group (51.5%) (p-value < 0.001). We noted statistically significant differences between the two study groups in relation to different tissue lesions (LDH), particularly at the pulmonary (CT severity score), hepatic (AST, ALT), and muscular levels (Creatine kinase). In addition, an exacerbated procoagulant and inflammatory profile in the study group was observed. The CART algorithm approach yielded decision paths that helped sort the risk of AKI progression into three categories: the low-risk category (0–40%), the medium-risk category (40–80%), and the high-risk category (>80%). It recognized specific inflammatory and renal biomarker profiles with particular cut-off points for procalcitonin, ferritin, LDH, creatinine, initial urea, and creatinine levels as important predictive factors of AKI outcomes (93.3% overall performance). Conclusions: Our study revealed the association between particular risk factors and AKI progression in COVID-19 patients. Diabetes, dyspnea on admission, the need for supplemental oxygen, and admission to the intensive care unit all had a crucial role in producing unfavorable outcomes, with a death rate of more than 50%. Necessary imaging studies (CT scan severity score) and changes in specific biomarker levels (ferritin and C-reactive protein levels) were also noted. These factors should be further investigated in conjunction with the pathophysiological mechanisms of AKI progression in COVID-19 patients." @default.
• W4386222848 created "2023-08-29" @default.
• W4386222848 creator A5004503505 @default.
• W4386222848 creator A5026439006 @default.
• W4386222848 creator A5045375634 @default.
• W4386222848 creator A5053921710 @default.
• W4386222848 creator A5072567848 @default.
• W4386222848 date "2023-08-26" @default.
• W4386222848 modified "2023-10-18" @default.
• W4386222848 title "Our Experience with SARS-CoV-2 Infection and Acute Kidney Injury: Results from a Single-Center Retrospective Observational Study" @default.
• W4386222848 cites W1978349722 @default.
• W4386222848 cites W1988248248 @default.
• W4386222848 cites W2024247761 @default.
• W4386222848 cites W2102556842 @default.
• W4386222848 cites W2111756308 @default.
• W4386222848 cites W2124641083 @default.
• W4386222848 cites W2170037826 @default.
• W4386222848 cites W2314787815 @default.
• W4386222848 cites W2513843070 @default.
• W4386222848 cites W2573036173 @default.
• W4386222848 cites W2765086424 @default.
• W4386222848 cites W2790127336 @default.
• W4386222848 cites W3008827533 @default.
• W4386222848 cites W3011605790 @default.
• W4386222848 cites W3012180666 @default.
• W4386222848 cites W3013180764 @default.
• W4386222848 cites W3013486442 @default.
• W4386222848 cites W3015383388 @default.
• W4386222848 cites W3016566297 @default.
• W4386222848 cites W3020247120 @default.
• W4386222848 cites W3024302853 @default.
• W4386222848 cites W3025305522 @default.
• W4386222848 cites W3029590896 @default.
• W4386222848 cites W3036966574 @default.
• W4386222848 cites W3037590441 @default.
• W4386222848 cites W3039834989 @default.
• W4386222848 cites W3039865750 @default.
• W4386222848 cites W3041996606 @default.
• W4386222848 cites W3047124721 @default.
• W4386222848 cites W3086996986 @default.
• W4386222848 cites W3091873439 @default.
• W4386222848 cites W3094836978 @default.
• W4386222848 cites W3108347817 @default.
• W4386222848 cites W3111197654 @default.
• W4386222848 cites W3116446264 @default.
• W4386222848 cites W3118889841 @default.
• W4386222848 cites W3120233339 @default.
• W4386222848 cites W3120244963 @default.
• W4386222848 cites W3126480559 @default.
• W4386222848 cites W3132414024 @default.
• W4386222848 cites W3135272772 @default.
• W4386222848 cites W3138554227 @default.
• W4386222848 cites W3157327242 @default.
• W4386222848 cites W3165520518 @default.
• W4386222848 cites W3179081715 @default.
• W4386222848 cites W3209673672 @default.
• W4386222848 cites W4206245015 @default.
• W4386222848 cites W4213283705 @default.
• W4386222848 cites W4213331168 @default.
• W4386222848 cites W4225571959 @default.
• W4386222848 cites W4225854543 @default.
• W4386222848 cites W4239060078 @default.
• W4386222848 cites W4283025351 @default.
• W4386222848 cites W4294225489 @default.
• W4386222848 cites W4304585354 @default.
• W4386222848 cites W4308429122 @default.
• W4386222848 cites W4313341441 @default.
• W4386222848 cites W4322753668 @default.
• W4386222848 cites W4378901568 @default.
• W4386222848 doi "https://doi.org/10.3390/healthcare11172402" @default.
• W4386222848 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37685436" @default.
• W4386222848 hasPublicationYear "2023" @default.
• W4386222848 type Work @default.
• W4386222848 citedByCount "0" @default.
• W4386222848 crossrefType "journal-article" @default.
• W4386222848 hasAuthorship W4386222848A5004503505 @default.
• W4386222848 hasAuthorship W4386222848A5026439006 @default.
• W4386222848 hasAuthorship W4386222848A5045375634 @default.
• W4386222848 hasAuthorship W4386222848A5053921710 @default.
• W4386222848 hasAuthorship W4386222848A5072567848 @default.
• W4386222848 hasBestOaLocation W43862228481 @default.
• W4386222848 hasConcept C126322002 @default.
• W4386222848 hasConcept C144301174 @default.
• W4386222848 hasConcept C167135981 @default.
• W4386222848 hasConcept C2777878052 @default.
• W4386222848 hasConcept C2779134260 @default.
• W4386222848 hasConcept C2779541074 @default.
• W4386222848 hasConcept C2780073493 @default.
• W4386222848 hasConcept C2780472472 @default.
• W4386222848 hasConcept C38180746 @default.
• W4386222848 hasConcept C71924100 @default.
• W4386222848 hasConcept C90924648 @default.
• W4386222848 hasConceptScore W4386222848C126322002 @default.
• W4386222848 hasConceptScore W4386222848C144301174 @default.
• W4386222848 hasConceptScore W4386222848C167135981 @default.
• W4386222848 hasConceptScore W4386222848C2777878052 @default.
• W4386222848 hasConceptScore W4386222848C2779134260 @default.
• W4386222848 hasConceptScore W4386222848C2779541074 @default.

• next